Pneumococcal Diseases: Vaccination

Department of Health and Social Care written question – answered on 7th March 2018.

Alert me about debates like this

Photo of Baroness Masham of Ilton Baroness Masham of Ilton Crossbench

To ask Her Majesty's Government what assessment they have made of the public health benefits of adopting the recommendation made by the Joint Committee on Vaccination and Immunisation at its meeting in October 2017 that the pneumococcal immunisation programme move to a 1 plus 1 schedule.

Photo of Lord O'Shaughnessy Lord O'Shaughnessy The Parliamentary Under-Secretary for Health and Social Care

The Government bases its vaccination programmes on the advice of the Joint Committee on Vaccination and Immunisation (JCVI), an independent expert group.

In October 2017, the JCVI considered all relevant evidence on the pneumococcal conjugate vaccine (PCV) and reviewed modelling undertaken by Public Health England on the impact of a reduced-dose PCV schedule in the United Kingdom. The JCVI advised a revised schedule for PCV with two doses of vaccine offered (a “1+1” schedule) rather than three. The JCVI is currently consulting on and reviewing its advice and will agree its final advice at a future Committee meeting, which will take into account public health arguments. The Department will consider and respond to this final advice in due course.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.